BridgeBio Pharma, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
BridgeBio Pharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2024.
  • BridgeBio Pharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.6M, a 27.6% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Operating Lease, Payments for 2023 was $4.83M, a 22.7% decline from 2022.
  • BridgeBio Pharma, Inc. annual Operating Lease, Payments for 2022 was $6.25M, a 2.01% increase from 2021.
  • BridgeBio Pharma, Inc. annual Operating Lease, Payments for 2021 was $6.12M, a 46.8% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.6M +$345K +27.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $1.25M -$570K -31.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $1.82M +$350K +23.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $4.91M $1.47M +$740K +101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $4.17M $639K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $1.1M Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.7M Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $730K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.